<DOC>
	<DOCNO>NCT01183442</DOCNO>
	<brief_summary>The main aim investigation clarify , whether vitamin D supplementation coronary artery disease patient vitamin D deficiency postchallenge hyperglycemia impact endothelial dysfunction parameter insulin sensitivity beta-cell function .</brief_summary>
	<brief_title>Vitamin D Supplementation CAD Postchallenge Hyperglycemia</brief_title>
	<detailed_description>An improvement endothelial dysfunction cardiovascular surrogate parameter could translate reduce risk future cardiovascular event , major interest , since patient postchallenge hyperglycemia face significantly high cardiovascular risk patient normal glucose tolerance . Furthermore improvement insulin sensitivity and/or beta-cell function would identify vitamin D important strategy prevention type 2 diabetes . In consideration rapidly increase prevalence diabetes failure current prevention strategy could important , safe cheap way support ongoing lifestyle modifying program . Our study course investigate surrogate cardiovascular insulin sensitivity parameter . Assuming beneficial effect vitamin D study , concept would prove large outcome well diabetes prevention trial .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Age 4075 Postchallenge hyperglycemia ( 2hwhole blood glucose value oral glucose tolerance test 119 mg/dl , normal fast glucose ) Angiographically verify coronary artery disease ( &gt; 50 % stenosis ) Serum 25OH vitamin D &lt; 20 ng/ml winter/spring/autumn &lt; 25 ng/ml juneseptember Stable antihypertensive therapy last 3 month Acute coronary syndrome cerebrovascular event within previous 1 month BMI &gt; 40 kg/mÂ² Serum creatinine &gt; 2.5 time upper limit normal GOT GPT &gt; 3 time upper limit normal Heart failure &gt; NYHA class II Uncontrolled hypertension ( &gt; 160/100 mmHg ) New onset statin , ACEinhibitors ARBs within previous 4 week History urolithiasis Hypercalcaemia Major psychiatric disorder Ongoing treatment spironolactone , canrenoate , eplerenone , amiloride , triamterene aliskiren . Treatment antipsychotic drug Regular significant antioxidant , vitamin protein supplementation Immunosuppressive therapy Glucocorticoid therapy Ongoing chemotherapy Pregnancy Any disease estimate life expectancy 1 year .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>endothelial function</keyword>
	<keyword>insulin sensitivity</keyword>
</DOC>